Prognostic value of tumor necrosis factor-alpha in patients with ST-segment elevation acute myocardial infarction;Valor pronóstico del factor de necrosis tumoral alfa en pacientes con infarto agudo de miocardio con elevación del segmento ST

Revista Espanola de Cardiologia

Volumn 60, Issue 12, 2007, Pages 1233-1241

  Gonzálvez Ortega, Manuel ^a   Ruiz Ros, José A ^a   Pérez Paredes, Matías ^a   Lozano, María L ^a   García Almagro, Francisco J ^a   Martínez Corbalán, Francisco ^a   Giménez, Diego M ^a   Carrillo, Andrés ^a   Carnero, Andrés ^a   Cubero, Tomás ^a   Gonzálvez, Juan J ^a   Ureña, Isabel ^a   Vicente, Vicente ^a  

^a HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

Inflammation; Interleukins; Myocardial infarction; Prognosis; Tumor necrosis factor alpha

Indexed keywords

C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEATH; DIAGNOSTIC VALUE; FEMALE; HEART FAILURE; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION;

EID: 37349040818     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13113928     Document Type: Article

References (25)

1. Angiolillo DJ, Biasucci LM, Liuzzo G, Crea F. La inflamación en los síndromes coronarios agudos: m ecanismos e implicaciones clínicas. Rev Esp Cardiol. 2004;57:433-46.
2. Petersen JW, Felker GM. Inflammatory biomarkers in heart failure. Congest Heart Fail. 2006;12:324-8.
3. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, et al. Tissue expression and inmunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation. 1999;99:1492-8.
4. Barath P, Fishbein MC, Cao J, Berenson J, Helfand RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 1990;65:297-302.
5. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the database from the Vesnarinone trial (VEST). Circulation. 2001;103:2055-9.
6. Herrera-Garza EH, Herrera-Garza JL, Rodríguez H, Treviño A, Ibarra M, Torre-Amione G. Importancia del factor de necrosis tumoral alfa en la patogenia de la insuficiencia cardiaca. Rev Esp Cardiol. 2002;55:61-6.
7. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000;102:3060-7.
8. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-α and increased of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149-53.
9. Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G, et al. Tumor necrosis factor-α receptor-1 is a major predicor of mortality and new-onset heart failure in patients with acute myocardial infarction. The Cytokine-Activation and Long-Term Prognosis in Myocardial infarction (C-ALPHA) Study. Circulation. 2005;111:863-70.
10. Arós F, Cuñat J, Loma-Osorio A, Torrado E, Boch X, Rodríguez JJ, et al. Tratamiento del infarto agudo de miocardio en España en el año 2000. El estudio PRIAMHO II. Rev Esp Cardiol. 2003;56:1165-73.
11. Valgimigli M, Merli E, Malagutti P, Soukhomovskaia O, Cicchitelli G, Antelli A, et al. Hidroxyl radical generation, levels of tumor necrosis factor-alpha, and progresion to heart failure after acute myocardial infarction. J Am Coll Cardiol. 2004;43:2000-8.
12. Nian M, Lee P, Khaper N, Liu P. Inflammatory citokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543-53.
13. Gurevitch J, Frolkis I, Yuhas Y, Lifschitz-Mercer B, Merger E, Paz Y, et al. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol. 1997;30:1554-61.
14. Sun M, Dawood F, Wen W-H, Chen M, Dixon I, KirshenbumLiu PP. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation. 2004;110:3221-8.
15. Saraste A, Voipio-Pulkki LM, Laine P, Nieminem MS, Pulkki K. Soluble tumor necrosis factor receptor levels identify a subgroup of heart failure patients wit increased cardiomyocyte apoptosis. Clin Cim Acta. 2002;320:65-7.
16. Sitges M, Roig E, Morales M, Azqueta M, Pérez Villa F, Paré C, et al. La disfunción endotelial en la miocardiopatía dilatada idiópática se asocia con disfunción ventricular y concentraciones plasmáticas elevadas de factor de necrosis turmoral. Rev Esp Cardiol. 2005;58:477-83.
17. Abbate A, Biondi-Zoccai GG, Bussani R, Dobrina A, Camilot D, Feroce F, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symtomatic post-infarction heart failure. J Am Coll Cardiol. 2003;41:753-60.
18. Jordán AJ, Esteban A, García M, Monmeneu JV, Espinosa D, Reyes F, et al. Valor pronóstico de los niveles séricos del factor de necrosis tumoral alfa en pacientes con insuficiencia cardíaca. Rev Esp Cardiol. 2003;56:160-7.
19. Hirschl MM, Gwechenberger M, Binder T, Binder M, Graf S, Stefenelli T, et al. Assessment of myocardial injury by serum tumor necrosis factor alpha measurements in acute myocardial infarction. Eur Heart J. 1996;17:1852-9.
20. Suleiman M, Khatib R, Agmon Y, Mahamadid R, Boulos M, Kapeliovich M, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol. 2006;47:962-8.
21. Núñez J, Fácila L, Llácer A, Sachis J, Bodí V, Bertomeu V, et al. Valor pronóstico del recuento leucocitario en el infarto agudo de miocardio: mortalidad a largo plazo. Rev Esp Cardiol. 2005;58:631-9.
22. Hurtado-Martínez J, Pinar-Bermúdez E, Teruel-Carrillo E, Gimeno-Blanes JR, Lacunza-Ruiz J, Valdesuso R, et al. Mortalidad a corto y largo plazo en mujeres con infarto de miocardio. Rev Esp Cardiol. 2006;11:1112-22.
23. Lewis EF, Moye LA, Rouleau JL, Sacks FM, Arnold MO, Warnika JW, et al. Predictors of late development of heart failure in stable survivors of myocardial infarction. J Am Coll Cardiol. 2003;42:1446-53.
24. Biasucci LM, Liuzzo G, Fantuzii G, Caligiuri G, Rebuzzi A, Ginnetti F. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 day of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation. 1999;99:2079-84.
25. Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, et al. B-Type Natriuretic Peptide at presentation and prognosis in patients with ST-segment elevation myiocardial infarction: An ENTIRE-TIMI-23 substudy. J Am Coll Cardiol. 2004;44:335-9.